Brentuximab Biosimilar - Anti-CD30 Antibody - BSA and Azide free
Beschreibung
Recombinant chimeric monoclonal antibody to CD30.
Anwendungen
ELISA
Verdünnungen
ELISA: 1:5,000-10,000
Reaktivität
Human
Wirt
Chimeric
Klonalität
Monoclonal
Isotyp
IgG1
Konjugat
Unconjugated
Reinigung
Affinity chromatography.
Konzentration
Reconstitution dependent.
Produktform
Lyophilized
Rekonstitution
Reconstitute with distilled sterile water.
Formulierung
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Lagerung
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Allgemeine Hinweise
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Synonyme
CD 30, CD30 antigen, CD30L receptor, Cytokine receptor CD30, D1S166E, KI 1, KI 1 antigen, Ki-1 antigen, KI1, Lymphocyte activation antigen CD30, TNFRSF 8, Tnfrsf8, TNR8_HUMAN, Tumor necrosis factor receptor superfamily member 8
Haftungsausschluss
Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.
ELISA plate pre-coated by 2 µg/ml (100 µl/well) Recombinant Human CD30 Protein (6xHis Tag) (A318247) can bind Anti-CD30 Chimeric Antibody [Brentuximab Biosimilar] - Azide free (A318939) in a linear range of 0.13-80 µg/ml.
Alternative Produkte zum Anti-CD30 Antikörper (A318939)